| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |